Trials / Conditions / HER2 Expressing Solid Tumors
HER2 Expressing Solid Tumors
3 registered clinical trials studyying HER2 Expressing Solid Tumors — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Exp NCT07334119 | Myeloid Therapeutics | Phase 1 |
| Recruiting | Gene Therapy for HER-Positive Cancer (SENTRY-HER2) NCT07192432 | Vironexis Biotherapeutics Inc. | Phase 1 / Phase 2 |
| Completed | Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors NCT02386501 | Advaxis, Inc. | Phase 1 / Phase 2 |